Zevia schedules sale of 40,000 common shares
Zevia PBC reports a proposed sale of 40,000 shares of Common Stock via Merrill Lynch, scheduled on 03/03/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Zevia PBC reports a proposed sale of 40,000 shares of Common Stock via Merrill Lynch, scheduled on 03/03/2026.
The filing notes those shares relate to a restricted stock unit award that vested on 01/17/2025.
Insights
Form 144 flags a standard post‑vesting sale of RSU shares by an insider or related holder.
The filing lists 40,000 common shares to be sold through Merrill Lynch with a trade date of 03/03/2026. The shares are tied to an RSU award that vested on 01/17/2025, indicating these are insider‑origin shares becoming eligible for sale.
Timing, pricing, and buyer details are not provided in the excerpt; subsequent transaction reports will show actual execution details and proceeds.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.